These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17113231)

  • 1. Association of APOE with Parkinson disease age-at-onset in women.
    Buchanan DD; Silburn PA; Prince JA; Mellick GD
    Neurosci Lett; 2007 Jan; 411(3):185-8. PubMed ID: 17113231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset.
    Parsian A; Racette B; Goldsmith LJ; Perlmutter JS
    Genomics; 2002 Mar; 79(3):458-61. PubMed ID: 11863377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association between polymorphism of alpha 1-antichymotrypsin and apolipoprotein E gene and Parkinson's disease in Shanghai Hans].
    Hao Y; Xie H; Xu L
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1172-5. PubMed ID: 11769703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of alpha-synuclein Rep1 polymorphism and Parkinson's disease: influence of Rep1 on age at onset.
    Hadjigeorgiou GM; Xiromerisiou G; Gourbali V; Aggelakis K; Scarmeas N; Papadimitriou A; Singleton A
    Mov Disord; 2006 Apr; 21(4):534-9. PubMed ID: 16250025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease.
    Feldman B; Chapman J; Korczyn AD
    Acta Neurol Scand; 2006 Jan; 113(1):14-7. PubMed ID: 16367893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association of APOE and tau polymorphisms with dementia in Parkinson's disease.
    Ezquerra M; Campdelacreu J; Gaig C; Compta Y; Muñoz E; Martí MJ; Valldeoriola F; Tolosa E
    Neurosci Lett; 2008 Dec; 448(1):20-3. PubMed ID: 18930114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of apolipoprotein E and age at onset to Parkinson disease neuropathology.
    Ghebremedhin E; Del Tredici K; Vuksic M; Rüb U; Thal DR; Burbach GJ; Rosenberger A; Bickeböller H; Deller T; de Vos RA; Jansen Steur EN; Braak H
    J Neuropathol Exp Neurol; 2006 Feb; 65(2):116-23. PubMed ID: 16462203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson's disease.
    Blázquez L; Otaegui D; Sáenz A; Paisán-Ruiz C; Emparanza JI; Ruiz-Martinez J; Moreno F; Martí-Massó JF; López de Munain A
    Neurosci Lett; 2006 Oct; 406(3):235-9. PubMed ID: 16904828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5,10-methylenetetrahydrofolate reductase C677T gene polymorphism can influence age at onset of Parkinson's disease.
    Lin JJ; Yueh KC; Liu CS; Liu JT; Lin SZ
    Acta Neurol Taiwan; 2007 Sep; 16(3):150-7. PubMed ID: 17966954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia.
    Jasinska-Myga B; Opala G; Goetz CG; Tustanowski J; Ochudlo S; Gorzkowska A; Tyrpa J
    Arch Neurol; 2007 Feb; 64(2):261-5. PubMed ID: 17296843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is olfactory impairment in Parkinson disease related to phenotypic or genotypic characteristics?
    Verbaan D; Boesveldt S; van Rooden SM; Visser M; Marinus J; Macedo MG; Fang Y; Heutink P; Berendse HW; van Hilten JJ
    Neurology; 2008 Dec; 71(23):1877-82. PubMed ID: 19047559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the estrogen receptor beta gene and age of onset of Parkinson's disease.
    Westberg L; Håkansson A; Melke J; Shahabi HN; Nilsson S; Buervenich S; Carmine A; Ahlberg J; Grundell MB; Schulhof B; Klingborg K; Holmberg B; Sydow O; Olson L; Johnels EB; Eriksson E; Nissbrandt H
    Psychoneuroendocrinology; 2004 Sep; 29(8):993-8. PubMed ID: 15219649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E epsilon4 allele is associated with Parkinson disease risk in a Mexican Mestizo population.
    López M; Guerrero J; Yescas P; Boll MC; Familiar I; Ochoa A; Rasmussen A; Alonso ME
    Mov Disord; 2007 Feb; 22(3):417-20. PubMed ID: 17230455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The homozygote AA genotype of the alpha1-antichymotrypsin gene may confer protection against early-onset Parkinson's disease in women.
    Lin JJ; Yueh KC; Chang CY; Chen CH; Lin SZ
    Parkinsonism Relat Disord; 2004 Dec; 10(8):469-73. PubMed ID: 15542006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease.
    Tang G; Xie H; Xu L; Hao Y; Lin D; Ren D
    Am J Med Genet; 2002 May; 114(4):446-9. PubMed ID: 11992569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TOMM40 and APOE common genetic variants are not Parkinson's disease risk factors.
    Peplonska B; Safranow K; Gaweda-Walerych K; Maruszak A; Czyzewski K; Rudzinska M; Barcikowska M; Zekanowski C
    Neurobiol Aging; 2013 Aug; 34(8):2078.e1-2. PubMed ID: 23522842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CD14 monocyte receptor polymorphism and genetic susceptibility to Parkinson's disease for females.
    Lin JJ; Chen CH; Yueh KC; Chang CY; Lin SZ
    Parkinsonism Relat Disord; 2006 Jan; 12(1):9-13. PubMed ID: 16337421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of APOE alleles in incident Parkinson's disease. The Norwegian ParkWest Study.
    Vefring H; Haugarvoll K; Tysnes OB; Larsen JP; Kurz MW;
    Acta Neurol Scand; 2010 Dec; 122(6):438-41. PubMed ID: 20456244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson's disease patients.
    Bialecka M; Klodowska-Duda G; Kurzawski M; Slawek J; Gorzkowska A; Opala G; Bialecki P; Sagan L; Droździk M
    Parkinsonism Relat Disord; 2008 Dec; 14(8):636-40. PubMed ID: 18362084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between tau H2 haplotype and age at onset in frontotemporal dementia.
    Borroni B; Yancopoulou D; Tsutsui M; Padovani A; Sawcer SJ; Hodges JR; Spillantini MG
    Arch Neurol; 2005 Sep; 62(9):1419-22. PubMed ID: 16157749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.